Intelligence · Patents
Expiring patents (≤24 months)
Patent cliff watchlist — pharmaceutical patents approaching loss of exclusivity.
- Patents
- 1,230
Quick answer
1,230 pharmaceutical patents in our index expire within the next 24 months. Use year facets below for annual patent-cliff planning linked to company and drug profiles.
-
US 7179823
5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
granted -
US 7179826
Compositions useful as inhibitors of protein kinases
granted -
US 7179899
Composite antibodies of humanized human subgroup IV light chain capable of binding to TAG-72
granted -
US 7179462
α (2) macroglobulin receptor as a heat shock protein receptor and uses thereof
granted -
US 7179588
Assay for the detection of paclitaxel resistant cells in human tumors
granted -
US 7179621
Pigment epithelium-derived factor: sequence of the PEDF gene
granted -
US 7179794
Multivalent macrolide antibiotics
granted -
US 7179445
Cobalamin conjugates useful as imaging and therapeutic agents
granted -
US 7179894
Combinatorial selection of oligonucleotide aptamers
granted -
US 7179815
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
granted -
US 7179827
Thiazoles and methods of their use
granted -
US 7179834
Salinosporamides and methods for use thereof
granted -
US 7179888
Antigenic, non-toxic mutants of Clostridium septicum alpha toxin and vaccines, antibodies, sera, and methods of treatment therewith
granted -
US 7183307
Pyrazole-derived kinase inhibitors and uses thereof
granted -
US 7183388
Anti-MUC-1 single chain antibodies for tumor targeting
granted -
US 7182944
Methods of increasing distribution of nucleic acids
granted -
US 7183095
Cell culture system for synthesis of infectious hepatitis C virus
granted -
US 7183255
Method for stabilizing blood pressure in hemodialysis subjects
granted -
US 7183065
Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens
granted -
US 7183267
β-lactamase inhibitors and methods of use thereof
granted -
US 7183268
2-amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purine antiviral agents
granted -
US 7183272
Crystal forms of oxcarbazepine and processes for their preparation
granted -
US 7183292
Substituted pyrrolidine and related compounds
granted -
US 7183276
Azole compounds
granted -
US 7183313
Keto cannabinoids with therapeutic indications
granted -
US 7183334
Low temperature molding compositions with solid thermoplastic elastomer thickeners and fiber reinforcement
granted -
US 7183323
Sodium channel modulators
granted -
US 7183401
NOEY2 gene compositions and methods of use
granted -
US 7183415
Quinoline compound
granted -
US 7183389
Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC)
granted -
US 7186698
Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat
granted -
US 7186115
Advanced thermoplastics for orthodontics
granted -
US 7186542
Method of extracting virus from cell culture
granted -
US 7186413
Hydrogels and water soluble polymeric carriers for drug delivery
granted -
US 7186737
Inhibitors of p38
granted -
US 7189396
Delivery system using mAb 3E10 and mutants and/or functional fragments thereof
granted -
US 7189865
Thiomolybdate analogues and uses thereof
granted -
US 7189704
6-11 bicyclic ketolide derivatives
granted -
US 7189385
Tooth whitening compositions
granted -
US 7189513
Human papilloma virus immunoreactive peptides
granted -
US 7189393
Recombinant anti-tumor RNAse
granted -
US 7189744
Crystals of benzimidazole compounds
granted -
US 7189706
C2,5′-disubstituted and N6,C2,5′-trisubstituted adenosine derivatives and pharmaceutical compositions containing them
granted -
US 7189812
Human gene critical to fertility
granted -
US 7189749
Substituted phenoxyacetic acids
granted -
US 7189741
Indolylpiperidine derivatives as antihistaminic and antiallergic agents
granted -
US 7189828
Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof
granted -
US 7189861
Processes for preparing amorphous atorvastatin hemi-calcium
granted
Frequently asked questions
What is a patent cliff?
A patent cliff is when key pharmaceutical patents expire, opening markets to generics or biosimilars. This hub lists USPTO patents with approaching expiration dates.
Are expiration dates estimates?
Expiration dates derive from USPTO PatentsView grant dates and term estimates. Confirm with Orange Book, patent counsel, and USPTO records before investment decisions.